tamoxifen and tirzepatide More on this study on GLP-1 medications impact on breast cancer. Remember Could weight loss medication prevent

As an FDA-Registered 503B Outsourcing Facility, ProRx does not dispense to patients

published in Medicine Journal covering 47 randomized controlled trials confirmed that GLP-1 receptor agonists produced a mean weight reduction of 4.57 kg alongside significant improvements in BMI and waist circumference

Both drugs are highly addictive on their own and when taken together, the risks for becoming dependent or addicted can increase significantly

Their study confirmed GLP-1s increased the risk of nausea, vomiting, kidney stones, sleep disturbances and other gastrointestinal problems

Seek urgent medical help if you develop signs of gallbladder disease (persistent right upper abdominal pain, fever, jaundice), acute kidney injury (reduced urination, severe dehydration), or allergic reactions (rash, swelling, breathing difficulty)